8-bromo-1,4,4,6-tetramethyl-9-(trifluoromethyl)-5H-[1,2,4]triazolo[4,3-a]quinoxaline;8-(5-fluoro-1H-indol-7-yl)-1,4,4,6-tetramethyl-9-(trifluoromethyl)-5H-[1,2,4]triazolo[4,3-a]quinoxaline;8-(5-fluoro-3-iodo-1H-indol-7-yl)-1,4,4,6-tetramethyl-9-(trifluoromethyl)-5H-[1,2,4]triazolo[4,3-a]quinoxaline;8-(5-fluoro-3-prop-1-ynyl-1H-indol-7-yl)-1,4,4,6-tetramethyl-9-(trifluoromethyl)-5H-[1,2,4]triazolo[4,3-a]quinoxaline;5-fluoro-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole;prop-1-yne

C100H93BBrF16IN20O2 — CID 167588539

IUPAC8-bromo-1,4,4,6-tetramethyl-9-(trifluoromethyl)-5H-[1,2,4]triazolo[4,3-a]quinoxaline;8-(5-fluoro-1H-indol-7-yl)-1,4,4,6-tetramethyl-9-(trifluoromethyl)-5H-[1,2,4]triazolo[4,3-a]quinoxaline;8-(5-fluoro-3-iodo-1H-indol-7-yl)-1,4,4,6-tetramethyl-9-(trifluoromethyl)-5H-[1,2,4]triazolo[4,3-a]quinoxaline;8-(5-fluoro-3-prop-1-ynyl-1H-indol-7-yl)-1,4,4,6-tetramethyl-9-(trifluoromethyl)-5H-[1,2,4]triazolo[4,3-a]quinoxaline;5-fluoro-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole;prop-1-yne
SMILESC#CC.CC#Cc1c[nH]c2c(-c3cc(C)c4c(c3C(F)(F)F)-n3c(C)nnc3C(C)(C)N4)cc(F)cc12.CC1(C)OB(c2cc(F)cc3cc[nH]c23)OC1(C)C.Cc1cc(-c2cc(F)cc3c(I)c[nH]c23)c(C(F)(F)F)c2c1NC(C)(C)c1nnc(C)n1-2.Cc1cc(-c2cc(F)cc3cc[nH]c23)c(C(F)(F)F)c2c1NC(C)(C)c1nnc(C)n1-2.Cc1cc(Br)c(C(F)(F)F)c2c1NC(C)(C)c1nnc(C)n1-2
InChIInChI=1S/C25H21F4N5.C22H18F4IN5.C22H19F4N5.C14H17BFNO2.C14H14BrF3N4.C3H4/c1-6-7-14-11-30-21-16(14)9-15(26)10-18(21)17-8-12(2)20-22(19(17)25(27,28)29)34-13(3)32-33-23(34)24(4,5)31-20;1-9-5-12(13-6-11(23)7-14-15(27)8-28-18(13)14)16(22(24,25)26)19-17(9)29-21(3,4)20-31-30-10(2)32(19)20;1-10-7-14(15-9-13(23)8-12-5-6-27-18(12)15)16(22(24,25)26)19-17(10)28-21(3,4)20-30-29-11(2)31(19)20;1-13(2)14(3,4)19-15(18-13)11-8-10(16)7-9-5-6-17-12(9)11;1-6-5-8(15)9(14(16,17)18)11-10(6)19-13(3,4)12-21-20-7(2)22(11)12;1-3-2/h8-11,30-31H,1-5H3;5-8,28-29H,1-4H3;5-9,27-28H,1-4H3;5-8,17H,1-4H3;5,19H,1-4H3;1H,2H3
InChIKeyICSWJRYUIMZUOQ-UHFFFAOYSA-N
MW2128.57 g/mol
LogP26.10
Rot. Bonds4

About 8-bromo-1,4,4,6-tetramethyl-9-(trifluoromethyl)-5H-[1,2,4]triazolo[4,3-a]quinoxaline;8-(5-fluoro-1H-indol-7-yl)-1,4,4,6-tetramethyl-9-(trifluoromethyl)-5H-[1,2,4]triazolo[4,3-a]quinoxaline;8-(5-fluoro-3-iodo-1H-indol-7-yl)-1,4,4,6-tetramethyl-9-(trifluoromethyl)-5H-[1,2,4]triazolo[4,3-a]quinoxaline;8-(5-fluoro-3-prop-1-ynyl-1H-indol-7-yl)-1,4,4,6-tetramethyl-9-(trifluoromethyl)-5H-[1,2,4]triazolo[4,3-a]quinoxaline;5-fluoro-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole;prop-1-yne

8-bromo-1,4,4,6-tetramethyl-9-(trifluoromethyl)-5H-[1,2,4]triazolo[4,3-a]quinoxaline;8-(5-fluoro-1H-indol-7-yl)-1,4,4,6-tetramethyl-9-(trifluoromethyl)-5H-[1,2,4]triazolo[4,3-a]quinoxaline;8-(5-fluoro-3-iodo-1H-indol-7-yl)-1,4,4,6-tetramethyl-9-(trifluoromethyl)-5H-[1,2,4]triazolo[4,3-a]quinoxaline;8-(5-fluoro-3-prop-1-ynyl-1H-indol-7-yl)-1,4,4,6-tetramethyl-9-(trifluoromethyl)-5H-[1,2,4]triazolo[4,3-a]quinoxaline;5-fluoro-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole;prop-1-yne (PubChem CID 167588539) has the molecular formula C100H93BBrF16IN20O2 and a molecular weight of 2128.57 g/mol. Its IUPAC name is 8-bromo-1,4,4,6-tetramethyl-9-(trifluoromethyl)-5H-[1,2,4]triazolo[4,3-a]quinoxaline;8-(5-fluoro-1H-indol-7-yl)-1,4,4,6-tetramethyl-9-(trifluoromethyl)-5H-[1,2,4]triazolo[4,3-a]quinoxaline;8-(5-fluoro-3-iodo-1H-indol-7-yl)-1,4,4,6-tetramethyl-9-(trifluoromethyl)-5H-[1,2,4]triazolo[4,3-a]quinoxaline;8-(5-fluoro-3-prop-1-ynyl-1H-indol-7-yl)-1,4,4,6-tetramethyl-9-(trifluoromethyl)-5H-[1,2,4]triazolo[4,3-a]quinoxaline;5-fluoro-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole;prop-1-yne.

Molecular Properties

Compound Name8-bromo-1,4,4,6-tetramethyl-9-(trifluoromethyl)-5H-[1,2,4]triazolo[4,3-a]quinoxaline;8-(5-fluoro-1H-indol-7-yl)-1,4,4,6-tetramethyl-9-(trifluoromethyl)-5H-[1,2,4]triazolo[4,3-a]quinoxaline;8-(5-fluoro-3-iodo-1H-indol-7-yl)-1,4,4,6-tetramethyl-9-(trifluoromethyl)-5H-[1,2,4]triazolo[4,3-a]quinoxaline;8-(5-fluoro-3-prop-1-ynyl-1H-indol-7-yl)-1,4,4,6-tetramethyl-9-(trifluoromethyl)-5H-[1,2,4]triazolo[4,3-a]quinoxaline;5-fluoro-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole;prop-1-yne
PubChem CID167588539
Molecular FormulaC100H93BBrF16IN20O2
Molecular Weight2128.57 g/mol
Exact Mass2126.59
IUPAC Name8-bromo-1,4,4,6-tetramethyl-9-(trifluoromethyl)-5H-[1,2,4]triazolo[4,3-a]quinoxaline;8-(5-fluoro-1H-indol-7-yl)-1,4,4,6-tetramethyl-9-(trifluoromethyl)-5H-[1,2,4]triazolo[4,3-a]quinoxaline;8-(5-fluoro-3-iodo-1H-indol-7-yl)-1,4,4,6-tetramethyl-9-(trifluoromethyl)-5H-[1,2,4]triazolo[4,3-a]quinoxaline;8-(5-fluoro-3-prop-1-ynyl-1H-indol-7-yl)-1,4,4,6-tetramethyl-9-(trifluoromethyl)-5H-[1,2,4]triazolo[4,3-a]quinoxaline;5-fluoro-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole;prop-1-yne
SMILESC#CC.CC#Cc1c[nH]c2c(-c3cc(C)c4c(c3C(F)(F)F)-n3c(C)nnc3C(C)(C)N4)cc(F)cc12.CC1(C)OB(c2cc(F)cc3cc[nH]c23)OC1(C)C.Cc1cc(-c2cc(F)cc3c(I)c[nH]c23)c(C(F)(F)F)c2c1NC(C)(C)c1nnc(C)n1-2.Cc1cc(-c2cc(F)cc3cc[nH]c23)c(C(F)(F)F)c2c1NC(C)(C)c1nnc(C)n1-2.Cc1cc(Br)c(C(F)(F)F)c2c1NC(C)(C)c1nnc(C)n1-2
InChIInChI=1S/C25H21F4N5.C22H18F4IN5.C22H19F4N5.C14H17BFNO2.C14H14BrF3N4.C3H4/c1-6-7-14-11-30-21-16(14)9-15(26)10-18(21)17-8-12(2)20-22(19(17)25(27,28)29)34-13(3)32-33-23(34)24(4,5)31-20;1-9-5-12(13-6-11(23)7-14-15(27)8-28-18(13)14)16(22(24,25)26)19-17(9)29-21(3,4)20-31-30-10(2)32(19)20;1-10-7-14(15-9-13(23)8-12-5-6-27-18(12)15)16(22(24,25)26)19-17(10)28-21(3,4)20-30-29-11(2)31(19)20;1-13(2)14(3,4)19-15(18-13)11-8-10(16)7-9-5-6-17-12(9)11;1-6-5-8(15)9(14(16,17)18)11-10(6)19-13(3,4)12-21-20-7(2)22(11)12;1-3-2/h8-11,30-31H,1-5H3;5-8,28-29H,1-4H3;5-9,27-28H,1-4H3;5-8,17H,1-4H3;5,19H,1-4H3;1H,2H3
InChIKeyICSWJRYUIMZUOQ-UHFFFAOYSA-N
XLogP26.10
TPSA252.58 Ų
H-Bond Donors8
H-Bond Acceptors18
Rotatable Bonds4
Heavy Atoms141
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002128.57
LogP ≤ 526.10
H-Bond Donors ≤ 58
H-Bond Acceptors ≤ 1018

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'heavy_metal', 'substructure': 'N/A'}, {'alert_name': 'iodine', 'substructure': 'N/A'}, {'alert_name': 'triple_bond', 'substructure': 'N/A'}

Analyze 8-bromo-1,4,4,6-tetramethyl-9-(trifluoromethyl)-5H-[1,2,4]triazolo[4,3-a]quinoxaline;8-(5-fluoro-1H-indol-7-yl)-1,4,4,6-tetramethyl-9-(trifluoromethyl)-5H-[1,2,4]triazolo[4,3-a]quinoxaline;8-(5-fluoro-3-iodo-1H-indol-7-yl)-1,4,4,6-tetramethyl-9-(trifluoromethyl)-5H-[1,2,4]triazolo[4,3-a]quinoxaline;8-(5-fluoro-3-prop-1-ynyl-1H-indol-7-yl)-1,4,4,6-tetramethyl-9-(trifluoromethyl)-5H-[1,2,4]triazolo[4,3-a]quinoxaline;5-fluoro-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole;prop-1-yne with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 8-bromo-1,4,4,6-tetramethyl-9-(trifluoromethyl)-5H-[1,2,4]triazolo[4,3-a]quinoxaline;8-(5-fluoro-1H-indol-7-yl)-1,4,4,6-tetramethyl-9-(trifluoromethyl)-5H-[1,2,4]triazolo[4,3-a]quinoxaline;8-(5-fluoro-3-iodo-1H-indol-7-yl)-1,4,4,6-tetramethyl-9-(trifluoromethyl)-5H-[1,2,4]triazolo[4,3-a]quinoxaline;8-(5-fluoro-3-prop-1-ynyl-1H-indol-7-yl)-1,4,4,6-tetramethyl-9-(trifluoromethyl)-5H-[1,2,4]triazolo[4,3-a]quinoxaline;5-fluoro-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole;prop-1-yne?
The IUPAC name of 8-bromo-1,4,4,6-tetramethyl-9-(trifluoromethyl)-5H-[1,2,4]triazolo[4,3-a]quinoxaline;8-(5-fluoro-1H-indol-7-yl)-1,4,4,6-tetramethyl-9-(trifluoromethyl)-5H-[1,2,4]triazolo[4,3-a]quinoxaline;8-(5-fluoro-3-iodo-1H-indol-7-yl)-1,4,4,6-tetramethyl-9-(trifluoromethyl)-5H-[1,2,4]triazolo[4,3-a]quinoxaline;8-(5-fluoro-3-prop-1-ynyl-1H-indol-7-yl)-1,4,4,6-tetramethyl-9-(trifluoromethyl)-5H-[1,2,4]triazolo[4,3-a]quinoxaline;5-fluoro-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole;prop-1-yne (CID 167588539) is 8-bromo-1,4,4,6-tetramethyl-9-(trifluoromethyl)-5H-[1,2,4]triazolo[4,3-a]quinoxaline;8-(5-fluoro-1H-indol-7-yl)-1,4,4,6-tetramethyl-9-(trifluoromethyl)-5H-[1,2,4]triazolo[4,3-a]quinoxaline;8-(5-fluoro-3-iodo-1H-indol-7-yl)-1,4,4,6-tetramethyl-9-(trifluoromethyl)-5H-[1,2,4]triazolo[4,3-a]quinoxaline;8-(5-fluoro-3-prop-1-ynyl-1H-indol-7-yl)-1,4,4,6-tetramethyl-9-(trifluoromethyl)-5H-[1,2,4]triazolo[4,3-a]quinoxaline;5-fluoro-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole;prop-1-yne.
What is the SMILES notation for 8-bromo-1,4,4,6-tetramethyl-9-(trifluoromethyl)-5H-[1,2,4]triazolo[4,3-a]quinoxaline;8-(5-fluoro-1H-indol-7-yl)-1,4,4,6-tetramethyl-9-(trifluoromethyl)-5H-[1,2,4]triazolo[4,3-a]quinoxaline;8-(5-fluoro-3-iodo-1H-indol-7-yl)-1,4,4,6-tetramethyl-9-(trifluoromethyl)-5H-[1,2,4]triazolo[4,3-a]quinoxaline;8-(5-fluoro-3-prop-1-ynyl-1H-indol-7-yl)-1,4,4,6-tetramethyl-9-(trifluoromethyl)-5H-[1,2,4]triazolo[4,3-a]quinoxaline;5-fluoro-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole;prop-1-yne?
The canonical SMILES for 8-bromo-1,4,4,6-tetramethyl-9-(trifluoromethyl)-5H-[1,2,4]triazolo[4,3-a]quinoxaline;8-(5-fluoro-1H-indol-7-yl)-1,4,4,6-tetramethyl-9-(trifluoromethyl)-5H-[1,2,4]triazolo[4,3-a]quinoxaline;8-(5-fluoro-3-iodo-1H-indol-7-yl)-1,4,4,6-tetramethyl-9-(trifluoromethyl)-5H-[1,2,4]triazolo[4,3-a]quinoxaline;8-(5-fluoro-3-prop-1-ynyl-1H-indol-7-yl)-1,4,4,6-tetramethyl-9-(trifluoromethyl)-5H-[1,2,4]triazolo[4,3-a]quinoxaline;5-fluoro-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole;prop-1-yne is C#CC.CC#Cc1c[nH]c2c(-c3cc(C)c4c(c3C(F)(F)F)-n3c(C)nnc3C(C)(C)N4)cc(F)cc12.CC1(C)OB(c2cc(F)cc3cc[nH]c23)OC1(C)C.Cc1cc(-c2cc(F)cc3c(I)c[nH]c23)c(C(F)(F)F)c2c1NC(C)(C)c1nnc(C)n1-2.Cc1cc(-c2cc(F)cc3cc[nH]c23)c(C(F)(F)F)c2c1NC(C)(C)c1nnc(C)n1-2.Cc1cc(Br)c(C(F)(F)F)c2c1NC(C)(C)c1nnc(C)n1-2.
What is the InChIKey of 8-bromo-1,4,4,6-tetramethyl-9-(trifluoromethyl)-5H-[1,2,4]triazolo[4,3-a]quinoxaline;8-(5-fluoro-1H-indol-7-yl)-1,4,4,6-tetramethyl-9-(trifluoromethyl)-5H-[1,2,4]triazolo[4,3-a]quinoxaline;8-(5-fluoro-3-iodo-1H-indol-7-yl)-1,4,4,6-tetramethyl-9-(trifluoromethyl)-5H-[1,2,4]triazolo[4,3-a]quinoxaline;8-(5-fluoro-3-prop-1-ynyl-1H-indol-7-yl)-1,4,4,6-tetramethyl-9-(trifluoromethyl)-5H-[1,2,4]triazolo[4,3-a]quinoxaline;5-fluoro-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole;prop-1-yne?
The InChIKey is ICSWJRYUIMZUOQ-UHFFFAOYSA-N. The full InChI is InChI=1S/C25H21F4N5.C22H18F4IN5.C22H19F4N5.C14H17BFNO2.C14H14BrF3N4.C3H4/c1-6-7-14-11-30-21-16(14)9-15(26)10-18(21)17-8-12(2)20-22(19(17)25(27,28)29)34-13(3)32-33-23(34)24(4,5)31-20;1-9-5-12(13-6-11(23)7-14-15(27)8-28-18(13)14)16(22(24,25)26)19-17(9)29-21(3,4)20-31-30-10(2)32(19)20;1-10-7-14(15-9-13(23)8-12-5-6-27-18(12)15)16(22(24,25)26)19-17(10)28-21(3,4)20-30-29-11(2)31(19)20;1-13(2)14(3,4)19-15(18-13)11-8-10(16)7-9-5-6-17-12(9)11;1-6-5-8(15)9(14(16,17)18)11-10(6)19-13(3,4)12-21-20-7(2)22(11)12;1-3-2/h8-11,30-31H,1-5H3;5-8,28-29H,1-4H3;5-9,27-28H,1-4H3;5-8,17H,1-4H3;5,19H,1-4H3;1H,2H3.
What are the key properties of 8-bromo-1,4,4,6-tetramethyl-9-(trifluoromethyl)-5H-[1,2,4]triazolo[4,3-a]quinoxaline;8-(5-fluoro-1H-indol-7-yl)-1,4,4,6-tetramethyl-9-(trifluoromethyl)-5H-[1,2,4]triazolo[4,3-a]quinoxaline;8-(5-fluoro-3-iodo-1H-indol-7-yl)-1,4,4,6-tetramethyl-9-(trifluoromethyl)-5H-[1,2,4]triazolo[4,3-a]quinoxaline;8-(5-fluoro-3-prop-1-ynyl-1H-indol-7-yl)-1,4,4,6-tetramethyl-9-(trifluoromethyl)-5H-[1,2,4]triazolo[4,3-a]quinoxaline;5-fluoro-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole;prop-1-yne?
8-bromo-1,4,4,6-tetramethyl-9-(trifluoromethyl)-5H-[1,2,4]triazolo[4,3-a]quinoxaline;8-(5-fluoro-1H-indol-7-yl)-1,4,4,6-tetramethyl-9-(trifluoromethyl)-5H-[1,2,4]triazolo[4,3-a]quinoxaline;8-(5-fluoro-3-iodo-1H-indol-7-yl)-1,4,4,6-tetramethyl-9-(trifluoromethyl)-5H-[1,2,4]triazolo[4,3-a]quinoxaline;8-(5-fluoro-3-prop-1-ynyl-1H-indol-7-yl)-1,4,4,6-tetramethyl-9-(trifluoromethyl)-5H-[1,2,4]triazolo[4,3-a]quinoxaline;5-fluoro-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole;prop-1-yne has a molecular weight of 2128.57 g/mol, XLogP of 26.10, 4 rotatable bonds, 8 hydrogen bond donors, and 18 hydrogen bond acceptors.
Where does this data come from?
All data for 8-bromo-1,4,4,6-tetramethyl-9-(trifluoromethyl)-5H-[1,2,4]triazolo[4,3-a]quinoxaline;8-(5-fluoro-1H-indol-7-yl)-1,4,4,6-tetramethyl-9-(trifluoromethyl)-5H-[1,2,4]triazolo[4,3-a]quinoxaline;8-(5-fluoro-3-iodo-1H-indol-7-yl)-1,4,4,6-tetramethyl-9-(trifluoromethyl)-5H-[1,2,4]triazolo[4,3-a]quinoxaline;8-(5-fluoro-3-prop-1-ynyl-1H-indol-7-yl)-1,4,4,6-tetramethyl-9-(trifluoromethyl)-5H-[1,2,4]triazolo[4,3-a]quinoxaline;5-fluoro-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole;prop-1-yne is sourced from PubChem (CID 167588539), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).